Satisfaction with the Injection Experience of a New, Citrate-Free Formulation of Ixekizumab
ConclusionThe citrate-free ixekizumab formulation was preferred and well accepted by most patients who switched from the original ixekizumab formulation. Similar findings were seen for those newly initiating citrate-free ixekizumab.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Arthritis | Drugs & Pharmacology | Pain | Psoriasis | Psoriatic Arthritis | Rheumatology | Statistics | Study